F41.0 F40.01 F32 F33 F34
Conditions
Interventions
Group 1: The patients from the intervention group will be treated by a new treatment program which is especially developed for PREMA. On 4 treatment appointments, the general practitioner will apply a
Sponsors
Techniker Krankenkasse
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: depression (ICD-10 F.32-34), panic disorder with or without agoraphobia (ICD-10: F41.0 or F40.01), positive screening questionnaires, sufficient German language skills, private telephone, insured by a statutory health insurance
Exclusion criteria
Exclusion criteria: acute or chronic psychosis, acute suicidality, current psychotherapeutic treatment of anxiety, general practitioner does not recommend PREMA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Mental Health Index-5 (MHI-5) score is used for cross-illness measurement of mental health (depression and anxiety disorder) at the survey time T0, T1 and T2. The MHI-5 is a five question subscale of the Short Form (36) Health Survey (SF 36) and consists of a six-step response scale (1-6 points), in which the scores are added (total range: 5-30 points). A higher score on the scale indicates a better mental health status. After that the points of the scale are transformed by standard linear transformation so that the value range is 0-100. The internal consistency (Cronbach's alpha) is between 0.67 and 0.95. The main aim of the study is to strengthening the task of general practitioners in the care of patient with depression or anxiety/panic disorders through a therapy combination of case management, GP-guided exercises and blended care (eHealth) tools. The GP should quickly and competently develop an adequate treatment strategy and decide whether the patient must be referred to a specialist immediately or he can treat the patient himself. T0= Beginning T1= 6 month T2= 12 month | — |
Secondary
| Measure | Time frame |
|---|---|
| screening and final diagnosis; T-1 mental health (depression and anxiety disorder); T0-T2 depression level (PHQ-9); T1-T2 anxiety level (OASIS); T1-T2 number and subjective severity of panic attack; T0-T2 anxiety related avoidance behavior (MIA); T0-T2 quality of supply from chronic disease patients (PACIC); T0-T2 adherence for medical intake; T0-T2 quality of life; T0-T2 comorbidity; T0-T2 use of health care service; T0-T2 work absences; T0-T2 costs of health services; T0-T2 acceptance, attitude, expectation, feasibility, training, communication, job satisfaction, implementation of the intervention; T0-T2 T0= Beginning T1= 6 month T2= 12 month | — |
Countries
Germany
Contacts
Public ContactLena Zwanzleitner
Techniker Krankenkasse
Outcome results
None listed